Plaudit

Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration

  • O.L Gobbo
  • , S.M O'Mara

No endorsements

This article has not been endorsed yet.

Like this work?

Let others know. Sign in to add your endorsement.